Skip to main content
Newsroom

Newsroom

Latest News

For EU audience
Press Release: August 05, 2021

Amarin Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update

For UK audience
Press Release: May 11, 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) gives green light to a proven new treatment to reduce the risk of cardiovascular events

For EU audience
Press Release: March 30, 2021

The European Commission gives green light to a proven new treatment to reduce cardiovascular events such as heart attacks, strokes and cardiac deaths

For EU audience
Press Release: January 29, 2021

Amarin receives positive CHMP opinion for icosapent ethyl for cardiovascular risk reduction

Media inquiries

If you’re a journalist or media professional, please feel free to get in touch with our European media team, by calling +44 (0)191 640 3638 or email [email protected]. The team will only respond to calls and emails from journalists. If you have a general or product-specific inquiry, go to the contact form that can be found on the homepage.